Page results
-
The Team offers a highly specialised, tertiary service for conditions such as urethral strictures, post prostatectomy and post radiotherapy complications, congenital urological abnormalities such as exstrophy, external trauma and incontinence.
-
Information about the EGA Hospital Charity at UCLH
-
Information about Lutetium-177 PSMA radionuclide therapy for metastatic or treatment-resistant prostate cancer
-
Gastro-oesophageal reflux (GOR) is the effortless regurgitation of feeds/milk. It affects over 40% of babies.
-
In partnership with Camden MSK, our department has agreed to provide ultrasound-guided Caudal Epidural injections to patients referred by the Camden community MSK services.
-
Patient information for women who have chosen to have surgical management under general anaesthetic following a diagnosis of a miscarriage.
-
This page has been written for patients who are having radiotherapy or proton beam therapy to the oesophagus.
-
The pelvic pain management service at UCLH was established in 2006 and our clinicians have a wealth of experience in managing women with abdominal and pelvic pain, and especially with those who have experienced complications following mesh implantation.
-
Dr Riaz' clinical practice includes a wide range of radionuclide diagnostic and therapeutic procedures, including conventional Nuclear Medicine imaging, oncologic and non-oncological PET imaging, cardiac PET imaging, and radionuclide therapies for thyroid cancer, prostate cancer and other rare cancers.
-
UCLH's Haemostasis and thrombosis hub signposts patients to a range of services for blood disorders.
File results
-
FOI/2023/0290 - Specialist palliative care units within the Trust
-
FOI/2023/0294 - Patient entertainment
-
FOI/2023/0295 - Strikes and Trust use of the BMA rate card
-
FOI/2023/0304 - Chronic lymphocytic leukaemia treatments
-
FOI/2023/0449 - Endometriosis pathway
-
FOI/2023/0313 - Consent, confidentiality and information sharing in mental healthcare and suicide
-
FOI/2023/0310 - Biologic treatment/ medicines in dermatology
-
FOI/2023/0308 - Treatment for biologic and biosimilar products within rheumatology
-
FOI/2023/0301 - Meat served at the Trust that may contain nitrates or nitrites
-
FOI/2023/0300 - Post-mortem examinations for 2019, 2020, 2021 and 2022